WWC proteins–mediated compensatory mechanism restricts schwannomatosis driven by NF2 loss of function
Science Advances · 24.01.2025 · 11 (4)
DOI: 10.1126/sciadv.adp4765 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 24.01.2025. Verfasst von Xueying Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pediatrics, Children's Hospital of Fudan University, and Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of …. Hauptthemen laut MEDLINE: Neurilemmoma, Neurofibromin 2, Neurofibromatoses, Ubiquitin-Protein Ligases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
NF2-related schwannomatosis, previously known as neurofibromatosis type 2, is a genetic disorder characterized by nerve tumors due to NF2 gene mutations. Mice with Nf2 deletion develop schwannomas slowly with low penetrance, hence inconvenient for preclinical studies. Here, we show that NF2, by recruiting E3 ubiquitin ligases β-TrCP1/2, promotes WWC1-3 ubiquitination and degradation. In NF2 mutated cells, WWC1-3 accumulation is a compensatory mechanism to prevent YAP/TAZ hyperactivation and rapid tumorigenesis. Accordingly, we generate a synthetic mouse model with complete penetrance and short latency by concurrently deleting Nf2 and Wwc1/2 in Schwann cells. This model closely resembles NF2-related schwannomatosis in patients, as confirmed by histological and single-cell transcriptome analysis. Moreover, a cell line from mouse schwannomas and a syngeneic tumor model in immune-competent mice are established. Furthermore, a screen using established models has identified candidate drugs that effectively suppress schwannoma progression. Hence, this work has developed rapid and transplantable models that will facilitate both basic and translational research on NF2-related schwannomatosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Pediatrics, Children's Hospital of Fudan University, and Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, State Key Laboratory of Genetic En…
- Huashan Hospital and Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.
- Department of Obstetrics and Gynecology and Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.
- ENT Institute and Otorhinolaryngology Department of Affiliated Eye and ENT Hospital, State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai, China.
- Department of Neurology, Children's Hospital of Fudan University, National Children's Medical Center, Fudan University, Shanghai, China.
ORCID-Profile: Xueying Wang, Rui Zhu, Pengcheng Yu, Zhenxing Zhong, Yu Wang, Yuan Gu, Dan Ye, Kang Chen, Yilai Shu, Fa-Xing Yu
Zitieren
APA
Wang, X., Zhu, R., Yu, P., Qi, S., Zhong, Z., Jin, R., Wang, Y., Gu, Y., Ye, D., Chen, K., Shu, Y., Wang, Y., & Yu, F. X. (2025). WWC proteins–mediated compensatory mechanism restricts schwannomatosis driven by NF2 loss of function. Science Advances, 11(4). https://doi.org/10.1126/sciadv.adp4765
Vancouver
Wang X, Zhu R, Yu P, Qi S, Zhong Z, Jin R, et al. WWC proteins–mediated compensatory mechanism restricts schwannomatosis driven by NF2 loss of function. Science Advances. 2025;11(4). doi:10.1126/sciadv.adp4765
BibTeX
@article{Wang2025,
author = {Wang, Xueying and Zhu, Rui and Yu, Pengcheng and Qi, Sixian and Zhong, Zhenxing and Jin, Ruxin and Wang, Yu and Gu, Yuan and Ye, Dan and Chen, Kang and Shu, Yilai and Wang, Yi and Yu, Fa-Xing},
title = {WWC proteins–mediated compensatory mechanism restricts schwannomatosis driven by NF2 loss of function},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {4},
doi = {10.1126/sciadv.adp4765}
}
EUVIMED